Zentalis Pharmaceuticals, Inc. — All Filings
516 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
4
4/A
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
PRE 14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0001725160-20-000034 | Nov 9, 2020 | Sep 30, 2020 |
| 4 | FORM 4 | 0001725160-20-000024 | Oct 30, 2020 | Oct 28, 2020 |
| 8-K | 8-K | 0001725160-20-000022 | Oct 2, 2020 | Sep 30, 2020 |
| 4 | FORM 4 | 0001725160-20-000020 | Sep 1, 2020 | Aug 31, 2020 |
| 3 | FORM 3 | 0001725160-20-000019 | Sep 1, 2020 | Aug 31, 2020 |
| 8-K | 8-K | 0001725160-20-000015 | Aug 13, 2020 | Aug 12, 2020 |
| 10-Q | 10-Q | 0001725160-20-000016 | Aug 13, 2020 | Jun 30, 2020 |
| 424B4 | 424B4 | 0001193125-20-204824 | Jul 31, 2020 | — |
| 8-K | 8-K | 0001193125-20-206383 | Jul 31, 2020 | Jul 27, 2020 |
| EFFECT | — | 9999999995-20-001957 | Jul 29, 2020 | — |
| S-1/A | S-1/A | 0001193125-20-201069 | Jul 28, 2020 | — |
| CORRESP | — | 0001193125-20-199697 | Jul 27, 2020 | — |
| S-1 | S-1 | 0001193125-20-199653 | Jul 27, 2020 | — |
| CORRESP | — | 0001193125-20-199699 | Jul 27, 2020 | — |
| UPLOAD | — | 0000000000-20-006406 | Jul 14, 2020 | — |
| DRS | — | 0000950123-20-006923 | Jul 10, 2020 | — |
| 8-K | 8-K | 0001193125-20-185377 | Jul 2, 2020 | Jun 26, 2020 |
| 3 | FORM 3 SUBMISSION | 0000899243-20-018184 | Jul 1, 2020 | — |
| 4 | FORM 4 SUBMISSION | 0000899243-20-018186 | Jul 1, 2020 | — |
| SC 13G | — | 0000929638-20-000622 | May 29, 2020 | — |
| 8-K | 8-K | 0001725160-20-000006 | May 15, 2020 | — |
| 10-Q | 10-Q | 0001725160-20-000007 | May 15, 2020 | Mar 31, 2020 |
| SC 13G | ACQUISITION OF BENEFICIAL OWNERSHIP | 0001387131-20-003882 | Apr 15, 2020 | — |
| 4 | FORM 4 SUBMISSION | 0000899243-20-010606 | Apr 9, 2020 | Apr 7, 2020 |
| 4 | FORM 4 SUBMISSION | 0000899243-20-010605 | Apr 9, 2020 | Apr 7, 2020 |
| 4 | FORM 4 SUBMISSION | 0000899243-20-010604 | Apr 9, 2020 | Apr 7, 2020 |
| 4 | FORM 4 SUBMISSION | 0000899243-20-010607 | Apr 9, 2020 | Apr 7, 2020 |
| SC 13G | SC 13G | 0001104659-20-045152 | Apr 9, 2020 | — |
| 4 | FORM 4 SUBMISSION | 0000899243-20-010601 | Apr 9, 2020 | Apr 7, 2020 |
| 4 | OWNERSHIP DOCUMENT | 0001387131-20-003800 | Apr 8, 2020 | Apr 3, 2020 |
| S-8 | S-8 | 0001193125-20-100536 | Apr 7, 2020 | — |
| 424B4 | 424B4 | 0001193125-20-098801 | Apr 6, 2020 | — |
| SEC STAFF LETTER | — | 9999999997-20-001401 | Apr 6, 2020 | — |
| 3 | FORM 3 SUBMISSION | 0000899243-20-010232 | Apr 3, 2020 | — |
| 3 | FORM 3 SUBMISSION | 0000899243-20-010229 | Apr 3, 2020 | — |
| 3 | FORM 3 SUBMISSION | 0000899243-20-010227 | Apr 3, 2020 | — |
| 3 | FORM 3 SUBMISSION | 0000899243-20-010224 | Apr 3, 2020 | — |
| 3 | FORM 3 SUBMISSION | 0000899243-20-010223 | Apr 3, 2020 | — |
| 3 | FORM 3 SUBMISSION | 0000899243-20-010222 | Apr 3, 2020 | — |
| 3 | FORM 3 SUBMISSION | 0000899243-20-010220 | Apr 3, 2020 | — |
| 3 | FORM 3 SUBMISSION | 0000899243-20-010218 | Apr 3, 2020 | — |
| 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP | 0001387131-20-003711 | Apr 3, 2020 | — |
| CERT | 8A CERT | 0001354457-20-000138 | Apr 3, 2020 | — |
| 3 | FORM 3 SUBMISSION | 0000899243-20-010234 | Apr 3, 2020 | — |
| S-1MEF | S-1MEF | 0001193125-20-096862 | Apr 2, 2020 | — |
| 8-A12B | 8-A12B | 0001193125-20-096074 | Apr 2, 2020 | — |
| EFFECT | — | 9999999995-20-000670 | Apr 2, 2020 | — |
| CORRESP | — | 0001193125-20-092892 | Mar 31, 2020 | — |
| S-1/A | FORM S-1 AMENDMENT NO. 2 | 0001193125-20-091784 | Mar 31, 2020 | — |
| CORRESP | — | 0001193125-20-092900 | Mar 31, 2020 | — |